The answer is retatrutide's third receptor target: glucagon
However, the study used only one behavioral test (Elevated Plus Maze)
[1][2] Why CVS Caremark Dropped Zepbound Better pricing from Novo Nordisk: CVS Caremark negotiated preferred pricing for Wegovy (Novo Nordisk's GLP-1), making it their preferred option Cost control: GLP-1 medications are expensive (~$1,086/month for Zepbound), and PBMs manage costs by limiting options Exclusivity agreements: Drug manufacturers compete for preferred formulary status by offering rebates What This Means for Aetna Members Standard Aetna plans: Zepbound excluded for weight loss (Wegovy preferred) Self-funded employer plans: Can choose to keep Zepbound covered Covered alternatives: Wegovy, Saxenda, Qsymia remain on most Aetna formularies For more details on how CVS Caremark affects GLP-1 coverage across all insurers: Complete CVS Caremark Guide Now that you understand the CVS Caremark connection, your plan type determines whether you can override it
Based on currently available data, the use of weight loss medications is not recommended during pregnancy
It is not recommended to drink alcohol as it can affect the control of your blood sugar
This association held across different ages, sexes, and ethnicities, and remained consistent in follow-ups of up to three years